Beam Therapeutics Inc. (BEAM)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 10:59AM EDT. Market open.
| Previous close | 23.47 |
| Open | 23.56 |
| Bid | 23.19 x 400 |
| Ask | 29.79 x 200 |
| Day's range | 23.20 - 23.85 |
| 52-week range | 16.95 - 49.50 |
| Volume | |
| Avg. volume | 1,519,445 |
| Market cap | 1.915B |
| Beta (5Y monthly) | 1.77 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Beam Therapeutics (NASDAQ:BEAM) Is In A Good Position To Deliver On Growth Plans
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
- Fool.co.uk
2 stocks to buy in the high potential gene editing space
Gene editing is one of the most exciting and interesting investment opportunities. So, here are two stocks to consider buying in the space. The post 2 stocks to buy in the high potential gene editing space appeared first on The Motley Fool UK.
- Zacks
Why Is Beam Therapeutics (BEAM) Down 22.1% Since Last Earnings Report?
Beam Therapeutics (BEAM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
© 2024 Yahoo. All rights reserved.